期刊文献+

β-异硫氰酸苯乙酯多靶向抗肿瘤作用机制研究进展

Advances in multi-targeted anti-tumor mechanisms ofβ-phenethyl isothiocyanate
下载PDF
导出
摘要 全球癌症的发病率逐年攀升,癌症治疗已成为科学界和医学界的重要研究课题。β-异硫氰酸苯乙酯(phenethyl isothiocyanate,PEITC)来源于十字花科植物,是广泛被研究的异硫氰酸酯(isothiocyanate,ITC)家族成员之一。越来越多流行病学和病理学研究证实PEITC可以诱导肿瘤细胞周期阻滞和凋亡。PEITC通过调节多种分子机制实现其抗肿瘤作用。本文对这些相关文献进行分析整理,对PEITC药物多靶向抗肿瘤作用机制和潜在的分子靶点进行简要综述。 Cancer has very high mortality and increasing prevalence rates.And cancer therapy has become an important research topic in the scientific community and the medical profession.Phenethyl isothiocyanate(PEITC)is one of the most widely investigated isothiocyanates from the crucifers.Increasing evidences from epidemiological and pathological studies suggest that PEITC can induce cancer cell cycle arrest and apoptosis.It exerts its chemopreventive effect through regulation of diverse molecular mechanisms.Here,we summarize recent data regarding the multi-targeted anti-cancer activity mechanisms and potential molecular targets of PEITC.
出处 《中国临床药理学与治疗学》 CAS CSCD 2015年第2期217-222,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 肿瘤治疗 β-异硫氰酸苯乙酯 分子机制 cancer therapies β-phenylethyl isothiocyanate molecular mechanisms
  • 相关文献

参考文献48

  • 1Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer[J]. Cell,2006,124(4) :823- 835.
  • 2Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer[]]. Cell, 2010, 140 (6) : 883-899.
  • 3Pao W, Wang TY, Riely GJ, et al. KRAS Muta- tions and Primary Resistance of Lung Adenocarci- nomas to Gefitinib or Erlotinib[J]. PLoS Med, 2005,2(1) : e17.
  • 4Couzin J. Cancer drugs. Smart weapons prove tough to design[J]. Science,2002,298(5593) :522-525.
  • 5Bardelli A, Siena S. Molecular mechanisms of re- sistance to cetuximab and panitumumab in colorectal cancer[J]. J Clin Oncol, 2010,28(7) :1254-1261.
  • 6Haber DA, Settleman J. Overcoming acquired re- sistance to Iressa/Tarceva with inhibitors of a dif- ferent class[J]. Cell Cycle,2005,4(8) :1057-1059.
  • 7Nahta R, Esteva FJ. Herceptin: mechanisms of ac- tion and resistance[J]. Cancer Lett, 2006,232 (2) : 123-138.
  • 8Kopetz S. "Right drug for the right patient". Am Soc Clin Oncol Educ Book[M]. 2013, 2013: 115- 120.
  • 9Hecht SS. Chemoprevention of cancer by isothiocy- anates, modifiers of carcinogen metabolism [J]. J Nutr, 1999,129 (3) : 768S-774S.
  • 10Hecht SS. Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke[J]. Environ Health Perspect, 1997, 105 Suppl 4: 955- 963.

二级参考文献2

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部